Skip to Main Content

Paper Details

Insights From Survival Analyses During 12 Years of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration.
JAMA Ophthalmol
24
2021
Author NameAffiliation
Dun Jack FuMoorfields Eye Hospital National Health Service (NHS) Foundation Trust
Dun Jack FuUniversity College London Institute of Ophthalmology
Tiarnan D L KeenanDepartment of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health
Livia FaesMoorfields Eye Hospital National Health Service (NHS) Foundation Trust
Livia FaesUniversity College London Institute of Ophthalmology
Livia FaesEye Clinic of the Cantonal Hospital of Lucerne
Siegfried K WagnerMoorfields Eye Hospital National Health Service (NHS) Foundation Trust
Siegfried K WagnerUniversity College London Institute of Ophthalmology
Praveen J PatelMoorfields Eye Hospital National Health Service (NHS) Foundation Trust
Praveen J PatelUniversity College London Institute of Ophthalmology
Konstantinos BalaskasMoorfields Eye Hospital National Health Service (NHS) Foundation Trust
Konstantinos BalaskasUniversity College London Institute of Ophthalmology
Dawn A SimMoorfields Eye Hospital National Health Service (NHS) Foundation Trust
Dawn A SimUniversity College London Institute of Ophthalmology
Dawn A SimKing's College London
Catey Bunce
Irene M StrattonNational Institute for Health and Research Biomedical Center, Moorfields Eye Hospital
Pearse A KeaneMoorfields Eye Hospital National Health Service (NHS) Foundation Trust
Pearse A KeaneUniversity College London Institute of Ophthalmology
Pearse A KeaneKing's College London
  • 1 - 20

Datasets